Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,156 GBX | -0.12% | +7.88% | +14.68% |
05:18pm | AstraZeneca Says Calquence Combination Improves Progression-Free Survival in Phase 3 Mantle Cell Lymphoma Trial | MT |
04:46pm | AstraZeneca: research into respiratory diseases | CF |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 13,214.80 | 13,214.80 | 12,186.00 |
Spread/Res. | -8.01% | -8.01% | -0.25% |
Spread/Supp. | +11.91% | +11.91% | +11.05% |
Support | 10,862.00 | 10,862.00 | 10,946.00 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC